Lifecure Drugs And Formulations Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 15-07-2024
- Paid Up Capital ₹ 0.48 M
as on 15-07-2024
- Company Age 26 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 3.00 M
as on 15-07-2024
- Revenue -81.72%
(FY 2020)
- Profit -47.02%
(FY 2020)
- Ebitda -2578.62%
(FY 2020)
- Net Worth -15.51%
(FY 2020)
- Total Assets -82.62%
(FY 2020)
About Lifecure Drugs And Formulations
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.48 M.
The company has closed loans amounting to ₹3.00 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Krishna Gupta and Manish Jindal serve as directors at the Company.
- CIN/LLPIN
U24232PB1998PTC021939
- Company No.
021939
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Nov 1998
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Jalandhar, Punjab, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Lifecure Drugs And Formulations?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manish Jindal  | Managing Director | 12-Nov-1998 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Krishna Gupta | Director | 12-Nov-1998 | Current |
Financial Performance of Lifecure Drugs And Formulations.
Lifecure Drugs And Formulations Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 81.72% decrease. The company also saw a substantial fall in profitability, with a 47.02% decrease in profit. The company's net worth observed a substantial decline by a decrease of 15.51%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Lifecure Drugs And Formulations?
In 2018, Lifecure Drugs And Formulations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 29 Apr 1999 | ₹1.50 M | Satisfied |
Canara Bank Creation Date: 22 Apr 1999 | ₹1.50 M | Satisfied |
How Many Employees Work at Lifecure Drugs And Formulations?
Unlock and access historical data on people associated with Lifecure Drugs And Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lifecure Drugs And Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lifecure Drugs And Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
